Categories
Business Markets

Rocking Stock: Amgen Inc. (NASDAQ:AMGN), Vistra Energy Corp. (NYSE:VST), JPMorgan Chase & Co. (NYSE:JPM), Halliburton Company (NYSE:HAL)

Amgen Inc. (NASDAQ:AMGN), and UCB (Euronext Brussels: UCB) announced that the companies have been informed the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the Marketing Authorization Application for EVENITYTM (romosozumab) for the treatment of severe osteoporosis. The companies intend to submit a written notice for a re-examination by the CHMP.

Amgen Inc. (NASDAQ:AMGN), a Healthcare sector firm, traded 2.19 Million shares in last trading session with closing price of $184.02 per share. Company gross margin stands at 82.30% whereas its return on investment (ROI) is 19.80%. Stock value has moved between $165.78 – 209.11 in last one year. Analyst’s mean target price for Amgen Inc. (NASDAQ:AMGN) is $205.55 while analysts mean recommendation is 2.20. AMGN EPS growth this year is 14.80%. 

On last trading day, Vistra Energy Corp. (NYSE:VST) shares closed at $22.24 per share. VST market capitalization is 10773.50. Analyst’s mean target price for Vistra Energy Corp. (NYSE:VST) is $33.50 whereas analysts mean recommendation is 1.80. Its weekly performance is -8.06% while year to date (YTD) performance is -2.84%. 

In last session JPMorgan Chase & Co. (NYSE:JPM) traded 10.79 Million shares and was closed at $108.84. Analyst’s mean target price for JPM is $118.84 while analysts mean recommendation is 2.30. Company is -8.72% away from its 52 week high and is moving 19.46% ahead of its 52 week low. JPM return on assets is 1.20%. JPMorgan Chase & Co. (NYSE:JPM) quarterly performance is 8.07% while its price to sale ratio is 4.35. 

Halliburton Company (NYSE:HAL), a Basic Materials sector firm, traded 9.89 Million shares on last trading day with closing price of $22.73 per share. Company gross margin stands at 11.60% whereas its return on investment (ROI) is 11.40%. Stock value has moved between $21.05 – 47.35 in last one year. Analyst’s mean target price for Halliburton Company (NYSE:HAL) is $38.17 while analysts mean recommendation is 1.80. HAL EPS growth this year is 389.60%. 

Leave a Reply